Andrew R. Robbins - Feb 13, 2023 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
President and CEO, Director
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
Stock symbol
COGT
Transactions as of
Feb 13, 2023
Transactions value $
$0
Form type
4
Date filed
2/15/2023, 02:49 PM
Previous filing
Jun 24, 2022
Next filing
Jun 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $0 +525K $0.00 525K Feb 13, 2023 Common Stock 525K $13.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in equal monthly installments over a four year period.

Remarks:

Exhibit 24 - Power of Attorney